These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25804887)

  • 21. Efficacy of Fluorescence Technology vs Conventional Oral Examination for the Early Detection of Oral Pre-Malignant Lesions. A Clinical Comparative Study.
    Saini R; Cantore S; Saini SR; Mastrangelo F; Ballini A; Santacroce L
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):852-858. PubMed ID: 30659553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autofluorescence and early detection of mucosal lesions in patients at risk for oral cancer.
    Moro A; Di Nardo F; Boniello R; Marianetti TM; Cervelli D; Gasparini G; Pelo S
    J Craniofac Surg; 2010 Nov; 21(6):1899-903. PubMed ID: 21119451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study to evaluate the efficacy of toluidine blue and cytology in detecting oral cancer and dysplastic lesions.
    Rahman F; Tippu SR; Khandelwal S; Girish KL; Manjunath BC; Bhargava A
    Quintessence Int; 2012 Jan; 43(1):51-9. PubMed ID: 22259809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Little evidence for the effectiveness of chemiluminescence and autofluorescent imaging devices as oral cancer screening adjuncts.
    Spivakovsky S; Gerber MG
    Evid Based Dent; 2015 Jun; 16(2):48. PubMed ID: 26114787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adjunctive role of toluidine blue in detection of oral premalignant and malignant lesions.
    Epstein JB; Güneri P
    Curr Opin Otolaryngol Head Neck Surg; 2009 Apr; 17(2):79-87. PubMed ID: 19374030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic efficiency of toluidine blue with Lugol's iodine in oral premalignant and malignant lesions.
    Nagaraju K; Prasad S; Ashok L
    Indian J Dent Res; 2010; 21(2):218-23. PubMed ID: 20657091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions.
    Mehrotra R; Singh M; Thomas S; Nair P; Pandya S; Nigam NS; Shukla P
    J Am Dent Assoc; 2010 Feb; 141(2):151-6. PubMed ID: 20123872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of toluidine blue staining and brush biopsy in precancerous and cancerous oral lesions.
    Gupta A; Singh M; Ibrahim R; Mehrotra R
    Acta Cytol; 2007; 51(5):788-94. PubMed ID: 17910350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of autofluorescence to identify suspicious oral lesions--a prospective, blinded clinical trial.
    Koch FP; Kaemmerer PW; Biesterfeld S; Kunkel M; Wagner W
    Clin Oral Investig; 2011 Dec; 15(6):975-82. PubMed ID: 20714910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toluidine blue staining in the detection of oral precancerous and malignant lesions.
    Silverman S; Migliorati C; Barbosa J
    Oral Surg Oral Med Oral Pathol; 1984 Apr; 57(4):379-82. PubMed ID: 6200814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic aids in the screening of oral cancer.
    Fedele S
    Head Neck Oncol; 2009 Jan; 1():5. PubMed ID: 19284694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity and specificity of OraScan (R) toluidine blue mouthrinse in the detection of oral cancer and precancer.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1996 Mar; 25(3):97-103. PubMed ID: 9148038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral cancer: Premalignant conditions and screening--an update.
    Nair DR; Pruthy R; Pawar U; Chaturvedi P
    J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S57-66. PubMed ID: 22322734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autofluorescence imaging to identify oral malignant or premalignant lesions: Systematic review and meta-analysis.
    Kim DH; Kim SW; Hwang SH
    Head Neck; 2020 Dec; 42(12):3735-3743. PubMed ID: 32866310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study.
    Rana M; Zapf A; Kuehle M; Gellrich NC; Eckardt AM
    Eur J Cancer Prev; 2012 Sep; 21(5):460-6. PubMed ID: 22217551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic value of the native fluorescence visualization device for early detection of premalignant/malignant lesions of the oral cavity.
    Amirchaghmaghi M; Mohtasham N; Delavarian Z; Shakeri MT; Hatami M; Mosannen Mozafari P
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():19-27. PubMed ID: 29079347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of the Microlux/DLTM chemiluminescence device in screening of potentially malignant and malignant oral lesions.
    Ibrahim SS; Al-Attas SA; Darwish ZE; Amer HA; Hassan MH
    Asian Pac J Cancer Prev; 2014; 15(15):6081-6. PubMed ID: 25124577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetic acid versus toluidine blue as screening tools for oral potentially malignant disorders.
    Winton Kalluvelil SR; Narayanan VS
    Indian J Cancer; 2023; 60(3):427-431. PubMed ID: 36861696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy.
    Kämmerer PW; Koch FP; Santoro M; Babaryka G; Biesterfeld S; Brieger J; Kunkel M
    Oral Oncol; 2013 May; 49(5):420-6. PubMed ID: 23318121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological Features Associated with Fluorescence Alteration: Analysis of 108 Oral Malignant and Potentially Malignant Lesions.
    Giovannacci I; Magnoni C; Pedrazzi G; Vescovi P; Meleti M
    Photobiomodul Photomed Laser Surg; 2021 Jan; 39(1):53-61. PubMed ID: 33332238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.